Rituximab efficacy at different initial and maintenance doses in neuromyelitis optica spectrum disorder: Experience from a national health institute in M éxico

NMOSD is an inflammatory disorder of the central nervous system that primarily affects the optic nerves and spinal cord. Rituximab (RTX) is a monoclonal antibody directed against CD20, an epitope expressed on pre-B and mature B cells. It has of wide use in several antibody-mediated autoimmune diseases.

Source: Journal of the Neurological Sciences - October 21, 2020 Category: Neurology Authors: Adriana Casallas-Vanegas, Enrique Gomez-Figueroa, Adib Jorge de Sar áchaga, Indhira Zabala-Angeles, Christian García-Estrada, Jorge C. Salado-Burbano, María Clara DiazGranados-Palacio, Teresita Corona-Vázquez, José de Jesús Flores-Rivera, Verónica Source Type: research